Korean Post-marketing Surveillance for Somavert
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• All patients who have been prescribed as per local label and investigators' judgement under the setting of routine practice in Korea who are eligible.
Locations
Other Locations
Republic of Korea
Pfizer
RECRUITING
Seoul
Contact Information
Primary
Pfizer CT.gov Call Center
ClinicalTrials.gov_Inquiries@pfizer.com
1-800-718-1021
Time Frame
Start Date: 2022-07-13
Estimated Completion Date: 2026-09-15
Participants
Target number of participants: 100
Treatments
Participants receiving Somavert
Related Therapeutic Areas
Sponsors
Leads: Pfizer